X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pai-1 (690) 690
humans (588) 588
index medicus (378) 378
plasminogen activator inhibitor 1 - genetics (374) 374
animals (355) 355
female (298) 298
male (282) 282
plasminogen activator inhibitor 1 - metabolism (237) 237
mice (187) 187
gene-expression (175) 175
plasminogen-activator inhibitor-1 (175) 175
expression (164) 164
hematology (163) 163
adult (161) 161
middle aged (156) 156
peripheral vascular disease (156) 156
gene expression (143) 143
cells, cultured (140) 140
fibrinolysis (140) 140
oncology (139) 139
biochemistry & molecular biology (138) 138
plasminogen activator inhibitor-1 (117) 117
cell biology (112) 112
endothelial-cells (112) 112
rna, messenger - metabolism (106) 106
plasminogen activator inhibitor 1 - biosynthesis (103) 103
aged (101) 101
myocardial-infarction (96) 96
rats (95) 95
growth-factor-beta (92) 92
rna, messenger - genetics (85) 85
type-1 (81) 81
plasminogen activator inhibitor 1 - blood (80) 80
tgf-beta (80) 80
analysis (76) 76
messenger-rna (75) 75
obesity (75) 75
gene expression regulation (74) 74
prognosis (74) 74
risk factors (72) 72
thrombosis (72) 72
upa (71) 71
genotype (69) 69
inflammation (69) 69
pai‐1 (69) 69
atherosclerosis (68) 68
genetic aspects (68) 68
fibrosis (66) 66
plasminogen-activator (66) 66
signal transduction (66) 66
urokinase-type plasminogen activator - metabolism (66) 66
mice, inbred c57bl (65) 65
cancer (64) 64
disease (64) 64
reverse transcriptase polymerase chain reaction (64) 64
pai-1 gene-expression (63) 63
cells (62) 62
immunohistochemistry (62) 62
insulin-resistance (61) 61
metastasis (61) 61
breast cancer (60) 60
cell line (60) 60
in-vivo (60) 60
enzyme-linked immunosorbent assay (59) 59
research (59) 59
article (58) 58
gene expression regulation - drug effects (58) 58
receptor (56) 56
urokinase-type plasminogen activator - genetics (56) 56
endocrinology & metabolism (55) 55
gene (55) 55
necrosis-factor-alpha (54) 54
polymorphism, genetic (53) 53
system (51) 51
thrombolytic drugs (50) 50
urokinase (50) 50
urology & nephrology (50) 50
aged, 80 and over (49) 49
cell line, tumor (49) 49
inhibitor pai-1 (49) 49
proteins (49) 49
mice, knockout (48) 48
pai-1 gene (48) 48
case-control studies (47) 47
medicine & public health (47) 47
transfection (47) 47
angiogenesis (46) 46
rna, messenger - analysis (46) 46
time factors (46) 46
up-regulation (46) 46
disease models, animal (45) 45
pharmacology & pharmacy (45) 45
promoter regions, genetic (45) 45
transcription (45) 45
cardiac & cardiovascular systems (44) 44
promoter (43) 43
rna, messenger - biosynthesis (43) 43
medicine, research & experimental (42) 42
metabolic syndrome (42) 42
polymorphism (42) 42
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


MOLECULAR PHARMACOLOGY, ISSN 0026-895X, 03/2012, Volume 81, Issue 3, pp. 338 - 347
The aryl hydrocarbon receptor (AhR) is a mediator of xenobiotic toxicity, best recognized for conveying the deleterious effects of... 
PAI-1 EXPRESSION | RETINOBLASTOMA PROTEIN | MOUSE HEPATOMA-CELLS | LIVER-REGENERATION | TYPE-1 GENE | TRANSCRIPTION | CYCLE ARREST | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | AH RECEPTOR | DIOXIN RECEPTOR | PHARMACOLOGY & PHARMACY
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 2006, Volume 339, Issue 2, pp. 624 - 632
Journal Article
Journal Article
THROMBOSIS AND HAEMOSTASIS, ISSN 0340-6245, 12/2008, Volume 100, Issue 6, pp. 976 - 983
Overexpression of plasminogen activator inhibitor-1 (SERPINEI, PAI-1), the major physiological inhibitor of pericellular plasmin generation, is a significant... 
cardiovascular disease | SMADs | TGF-BETA | Rho kinase | transcription | INDUCIBLE FACTOR-I | TGF-beta 1 | epidermal growth factor receptor | ADAPTER PROTEIN SHC | RHO-KINASE | NEOINTIMA FORMATION | pp60(c-src) | FACTOR RECEPTOR | EGFR | KINASE C-SRC | GROWTH-FACTOR-BETA | UPSTREAM STIMULATORY FACTOR | MAP kinases | PAI-1 | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | TRANSCRIPTION FACTOR | SERPINEI
Journal Article
Journal Article
Journal of Visualized Experiments, ISSN 1940-087X, 11/2017, Volume 2017, Issue 129
siRNA and shRNA-mediated knock down (KD) methods of regulating gene expression are invaluable tools for understanding gene and protein function. However, in... 
Conditional knock down | Monocytes | ShRNA | Doxycycline | Cancer Research | PAI-1 | Issue 129 | Cancer cell lines | Cell migration | TARGET | monocytes | RNAI SYSTEM | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | cancer cell lines | doxycycline | HUMAN MONOCYTES | shRNA | cell migration
Journal Article
Journal of Cell Science, ISSN 0021-9533, 2001, Volume 114, Issue 21, pp. 3905 - 3914
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 12/2008, Volume 100, Issue 6, pp. 976 - 983
Overexpression of plasminogen activator inhibitor-1 (SERPINE1, PAI-1), the major physiological inhibitor of pericellular plasmin generation, is a significant... 
Cardiovascular Disease | SMADs | Rho kinase | transcription | epidermal growth factor receptor | pp60c-src | SERPINE1 | MAP kinases | PAI-1 | TGF-β1 | EGFR | Theme Issue Article | Transcription | Cardiovascular disease | Epidermal growth factor receptor | pp60 | cardiovascular disease
Journal Article
JOURNAL OF CELL SCIENCE, ISSN 0021-9533, 11/2001, Volume 114, Issue 21, pp. 3905 - 3914
The type-1 inhibitor of plasminogen activator (PAI-1) is an important physiological regulator of extracellular matrix (ECM) homeostasis and cell motility.... 
signal transduction | TGF-beta 1 | MAP KINASE | PLASMINOGEN-ACTIVATOR INHIBITOR-1 | CELL BIOLOGY | SIGNAL-TRANSDUCTION | GROWTH-FACTOR-BETA | IN-VITRO | EPITHELIAL-CELLS | RAT-KIDNEY CELLS | TRANSFORMING GROWTH-FACTOR-BETA-1 | PAI-1 | EXTRACELLULAR-MATRIX DEGRADATION | CYTOSKELETON REORGANIZATION | gene expression
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 09/2005, Volume 68, Issue 3, pp. 972 - 984
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 9/2009, Volume 50, Issue 3, pp. 880 - 892
Plasminogen activator inhibitor type I (PAI-1) is a marker of the fibrinolytic system, and serves as a possible predictor for hepatic metabolic syndromes.... 
Fenofibrate | AMPK | PAI-1 | SHP
Journal Article
Cancer, ISSN 0008-543X, 09/2010, Volume 116, Issue 18, pp. 4248 - 4255
Journal Article
Journal Article